Literature DB >> 11339371

Endocrine aspects of the 22q11.2 deletion syndrome.

S A Weinzimer1.   

Abstract

Hormonal disorders are common in patients with a 22q11.2 deletion. While hypoparathyroidism was the first endocrine disturbance documented in the DiGeorge syndrome, growth hormone deficiency, hypothyroidism, and hyperthyroidism are now known to occur in patients with a 22q11.2 deletion. This review briefly summarizes our current understanding of the spectrum of endocrinological manifestations of the 22q11.2 deletion and proposes guidelines for appropriate screening and management of endocrine disorders in patients with a 22q11.2 deletion.

Entities:  

Mesh:

Year:  2001        PMID: 11339371     DOI: 10.1097/00125817-200101000-00005

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  24 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

2.  Hypocalcaemia in an adult: the importance of not overlooking the cause.

Authors:  Catarina Abrantes; Daniela Brigas; Hugo Jorge Casimiro; Margarida Madeira
Journal:  BMJ Case Rep       Date:  2018-04-05

3.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

Review 4.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

5.  Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.

Authors:  Erik Boot; Nancy J Butcher; Thérèse A M J van Amelsvoort; Anthony E Lang; Connie Marras; Margarita Pondal; Danielle M Andrade; Wai Lun Alan Fung; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2015-02-13       Impact factor: 2.802

6.  Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome.

Authors:  Fradique Moreira; Ana Brás; Joana Ramos Lopes; Cristina Januário
Journal:  BMJ Case Rep       Date:  2018-03-22

Review 7.  Head and neck manifestations of 22q11.2 deletion syndromes.

Authors:  Tal Marom; Yehudah Roth; Abraham Goldfarb; Udi Cinamon
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-23       Impact factor: 2.503

8.  Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome.

Authors:  Arpana Rayannavar; Lorraine E Levitt Katz; Terrence Blaine Crowley; Megan Lessig; Katheryn Grand; Elizabeth Goldmuntz; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-10-01       Impact factor: 2.802

9.  Bone density assessment in a cohort of pediatric patients affected by 22q11DS.

Authors:  A Ficcadenti; F Zallocco; R Neri; L Giovannini; G Tirabassi; G Balercia
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

Review 10.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.